2023
DOI: 10.1016/j.ymgme.2022.107198
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative systems pharmacology (QSP) analysis predicts that olipudase alfa treatment of patients with extreme acid sphingomyelinase deficiencies can result in meaningful debulking of visceral tissue sphingomyelin

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles